The ability of the different tumor cell lines to induce Siglec‐7 signalling was assessed, using our recently established chimeric Siglec‐7 (chSiglec‐7) Jurkat/MA signalling tool.32 This evidence concerns the gene SIGLEC7 and neoplasm.